These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 17085491

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 Neuraminidase.
    Prachanronarong KL, Özen A, Thayer KM, Yilmaz LS, Zeldovich KB, Bolon DN, Kowalik TF, Jensen JD, Finberg RW, Wang JP, Kurt-Yilmaz N, Schiffer CA.
    J Chem Theory Comput; 2016 Dec 13; 12(12):6098-6108. PubMed ID: 27951676
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
    Mohan S, McAtamney S, Haselhorst T, von Itzstein M, Pinto BM.
    J Med Chem; 2010 Oct 28; 53(20):7377-91. PubMed ID: 20873795
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases.
    Le L, Lee EH, Hardy DJ, Truong TN, Schulten K.
    PLoS Comput Biol; 2010 Sep 23; 6(9):. PubMed ID: 20885781
    [Abstract] [Full Text] [Related]

  • 31. [Design, synthesis and activity of a new type of influenza virus N1 neuraminidase inhibitors].
    Yang F, Jin L, Huang NY, Chen F, Luo HJ, Chen JF.
    Yao Xue Xue Bao; 2011 Nov 23; 46(11):1344-8. PubMed ID: 22260026
    [Abstract] [Full Text] [Related]

  • 32. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant.
    García-Sosa AT, Sild S, Maran U.
    J Chem Inf Model; 2008 Oct 23; 48(10):2074-80. PubMed ID: 18847186
    [Abstract] [Full Text] [Related]

  • 33. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Abed Y, Nehmé B, Baz M, Boivin G.
    Antiviral Res; 2008 Feb 23; 77(2):163-6. PubMed ID: 17919743
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of R292K mutation in influenza H7N9 neuraminidase toward oseltamivir susceptibility: MD and MM/PB(GB)SA study.
    Phanich J, Rungrotmongkol T, Kungwan N, Hannongbua S.
    J Comput Aided Mol Des; 2016 Oct 23; 30(10):917-926. PubMed ID: 27714494
    [Abstract] [Full Text] [Related]

  • 36. Molecular prediction of oseltamivir efficiency against probable influenza A (H1N1-2009) mutants: molecular modeling approach.
    Rungrotmongkol T, Malaisree M, Nunthaboot N, Sompornpisut P, Hannongbua S.
    Amino Acids; 2010 Jul 23; 39(2):393-8. PubMed ID: 20037767
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase.
    Wang Y, Wu D, Yu D, Wang Z, Tian L, Wang Y, Han W, Fang X.
    J Mol Model; 2012 Aug 23; 18(8):3445-53. PubMed ID: 22278046
    [Abstract] [Full Text] [Related]

  • 39. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
    Woods CJ, Malaisree M, Pattarapongdilok N, Sompornpisut P, Hannongbua S, Mulholland AJ.
    Biochemistry; 2012 May 29; 51(21):4364-75. PubMed ID: 22574858
    [Abstract] [Full Text] [Related]

  • 40. Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification.
    Steain MC, Dwyer DE, Hurt AC, Kol C, Saksena NK, Cunningham AL, Wang B.
    Antiviral Res; 2009 Dec 29; 84(3):242-8. PubMed ID: 19800370
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.